NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent...

Posted on: Tuesday, 13 May 2008, 03:00 CDT May 13, 2008. Sophia Antipolis, France. www.nicox.com NicOx S.A. (Eurolist: COX) today announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative... [read full story]                    

Add Comment
There are also 9 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies